Fosun Pharma USA and MAP International collaborate to increase access to essential pain relief in underserved communities. Fosun Pharma USA will donate ketorolac tromethamine injection, USP, a critical non-opioid pain reliever, through MAP’s international distribution network serving 300 on the ground partners and volunteer medical mission groups. Together, the two organizations aim to help in solving the pain management access gap, especially in areas facing shortages of medicines and limited medical infrastructure. Ketorolac tromethamine is commonly used for moderate to severe pain and is administered in surgical, postoperative, and trauma care settings. Its injectable formulation is ideal for rural clinics, mobile units, and emergency response situations.